Feasibility, Fidelity, and Effectiveness of Administering Long-Acting Cabotegravir + Rilpivirine in Infusion Centers in the United States: Findings From the Phase 4 GLACIER Implementation Study

Cassidy A. Gutner, Conn Harrington, Gilda Bontempo, Sivakumar Pazhamalai, Abhishek Kumar, Kelly Rimler, Karen Davis, Will Williams, Deanna Merrill, Lisa Petty, Cindy Garris, Supriya Sarkar, Patrick Daniele, Bridget Gaglio, Katie May, Michael Aboud, Maggie Czarnogorski

Journal of the International Association of Providers of AIDS Care (JIAPAC)

Published online on May 12, 2026

Abstract

Journal of the International Association of Providers of AIDS Care (JIAPAC), Volume 25, January-December 2026.
BackgroundGLACIER (Giving Long-Acting Cabotegravir plus rilpivirine [CAB + RPV LA] in an Infusion Center [IC]) is a Phase 4 implementation study evaluating the perspective of people living with HIV-1 (participants) and IC staff on CAB + RPV LA delivery at ...